These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 20167930

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.
    Eur J Pharmacol; 2005 Mar 21; 511(1):53-64. PubMed ID: 15777779
    [Abstract] [Full Text] [Related]

  • 7. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
    Wang S, Peng Q, Zhang J, Liu L.
    Cardiovasc Res; 2008 Nov 01; 80(2):255-62. PubMed ID: 18591204
    [Abstract] [Full Text] [Related]

  • 8. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S, Long CL, Wang RH, Wang H.
    Cardiovasc Res; 2009 Aug 01; 83(3):444-56. PubMed ID: 19304734
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clopidogrel improves endothelial function and NO bioavailability by sensitizing adenylyl cyclase in rats with congestive heart failure.
    Schäfer A, Fraccarollo D, Pförtsch S, Loch E, Neuser J, Vogt C, Bauersachs J.
    Basic Res Cardiol; 2011 May 01; 106(3):485-94. PubMed ID: 21287353
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S, Wakino S, Kanda T, Homma K, Yoshioka K, Hasegawa K, Sugano N, Kimoto M, Saruta T, Hayashi K.
    J Am Soc Nephrol; 2007 Mar 01; 18(3):741-9. PubMed ID: 17267746
    [Abstract] [Full Text] [Related]

  • 16. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N, Kaestle S, Yin J, Hentschel T, Pries AR, Kuppe H, Kuebler WM.
    Crit Care Med; 2009 Mar 01; 37(3):980-6. PubMed ID: 19237907
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Large-conductance K+ channel opener CGS7184 as a regulator of endothelial cell function.
    Wrzosek A, Łukasiak A, Gwóźdź P, Malińska D, Kozlovski VI, Szewczyk A, Chlopicki S, Dołowy K.
    Eur J Pharmacol; 2009 Jan 05; 602(1):105-11. PubMed ID: 19028489
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
    Schäfer A, Fraccarollo D, Eigenthaler M, Tas P, Firnschild A, Frantz S, Ertl G, Bauersachs J.
    Arterioscler Thromb Vasc Biol; 2005 May 05; 25(5):1071-7. PubMed ID: 15761193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.